CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a new method for controlling cell behavior in the treatment of neurodegenerative diseases, particularly Parkinson’s disease. By using magnetic nanoparticles to manipulate cellular functions, the project seeks to enhance cell replacement therapies through improved neuronal programming and gr…
Neurodegenerative diseases, such as Parkinson’s disease, are a major public health issue given the aging population inEurope and beyond.
While curative pharmacological treatment of these diseases is not in sight, cell replacement therapies(CTs) are considered very promising, in particular with the advent of stem-cell reprogramming technologies.
However, afundamental challenge in the medical application of CTs in the brain of patients lies in the lack of control of cell behaviour atthe site of tr…
INSTITUT CURIE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Paris
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Keele
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Osnabrueck
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
